Literature DB >> 27897918

Buprenorphine shared medical appointments for the treatment of opioid dependence in a homeless clinic.

Sara L Doorley1, Cheryl J Ho1, Elizabeth Echeverria1, Charles Preston1, Huy Ngo1, Ahmad Kamal1,2, Chinazo O Cunningham3.   

Abstract

BACKGROUND: Opioid misuse and dependence are prevalent and rising problems in the United States. Treatment with buprenorphine is a successful treatment option for individuals with opioid dependence. This study describes and preliminarily evaluates a unique delivery system that provides buprenorphine treatment via a shared medical appointment.
METHODS: A retrospective medical record review on all 77 opioid-dependent patients referred for a buprenorphine shared medical appointment in a homeless clinic from 2010 to 2012.
RESULTS: Most patients were currently homeless (61%), unemployed (92%), had an Axis I psychiatric diagnosis (81%), and had recent polysubstance use (53%). Of the 77 patients, 95% attended at least 1 shared medical appointment. Treatment retention at 12 and 24 weeks was 86% and 70%, respectively.
CONCLUSIONS: In a patient population with complex social and mental health histories, buprenorphine treatment via a shared medical appointment had high retention rates. Findings can help guide the development of unique delivery systems to serve real-world complex patients with opioid dependence.

Entities:  

Keywords:  Buprenorphine; group visit; homeless; office-based treatment; shared medical appointment

Mesh:

Substances:

Year:  2016        PMID: 27897918      PMCID: PMC5592108          DOI: 10.1080/08897077.2016.1264535

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  29 in total

1.  A controlled trial of buprenorphine treatment for opioid dependence.

Authors:  R E Johnson; J H Jaffe; P J Fudala
Journal:  JAMA       Date:  1992-05-27       Impact factor: 56.272

2.  The prevalence of homelessness among injection drug users with and without HIV infection.

Authors:  J Y Song; M Safaeian; S A Strathdee; D Vlahov; D D Celentano
Journal:  J Urban Health       Date:  2000-12       Impact factor: 3.671

3.  Group office visits change dietary habits of patients with coronary artery disease-the dietary intervention and evaluation trial (D.I.E.T.).

Authors:  S Masley; S Phillips; J R Copeland
Journal:  J Fam Pract       Date:  2001-03       Impact factor: 0.493

4.  Feasibility of Implementing Shared Medical Appointments (SMAs) for Office-Based Opioid Treatment With Buprenorphine: A Pilot Study.

Authors:  Joji Suzuki; Jennifer Zinser; Brenda Klaiber; Melanie Hannon; Hope Grassi; Madeline Spinosa; Altagracia Ramirez; Mohammed Issa; Siu Ping Chin Feman
Journal:  Subst Abus       Date:  2015       Impact factor: 3.716

5.  Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.

Authors:  Ira L Mintzer; Mark Eisenberg; Maria Terra; Casey MacVane; David U Himmelstein; Steffie Woolhandler
Journal:  Ann Fam Med       Date:  2007 Mar-Apr       Impact factor: 5.166

Review 6.  Risk of death among homeless women: a cohort study and review of the literature.

Authors:  Angela M Cheung; Stephen W Hwang
Journal:  CMAJ       Date:  2004-04-13       Impact factor: 8.262

7.  Mortality among homeless adults in Boston: shifts in causes of death over a 15-year period.

Authors:  Travis P Baggett; Stephen W Hwang; James J O'Connell; Bianca C Porneala; Erin J Stringfellow; E John Orav; Daniel E Singer; Nancy A Rigotti
Journal:  JAMA Intern Med       Date:  2013-02-11       Impact factor: 21.873

8.  Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

Authors:  W Ling; C Charuvastra; J F Collins; S Batki; L S Brown; P Kintaudi; D R Wesson; L McNicholas; D J Tusel; U Malkerneker; J A Renner; E Santos; P Casadonte; C Fye; S Stine; R I Wang; D Segal
Journal:  Addiction       Date:  1998-04       Impact factor: 6.526

Review 9.  Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction.

Authors: 
Journal:  JAMA       Date:  1998-12-09       Impact factor: 56.272

10.  Buprenorphine treatment in an urban community health center: what to expect.

Authors:  Chinazo Cunningham; Angela Giovanniello; Galit Sacajiu; Susan Whitley; Pamela Mund; Robert Beil; Nancy Sohler
Journal:  Fam Med       Date:  2008 Jul-Aug       Impact factor: 1.756

View more
  3 in total

1.  A crack in the wall: Chronic pain management in integrative group medical visits.

Authors:  Ariana Thompson-Lastad; Sara Rubin
Journal:  Soc Sci Med       Date:  2020-05-20       Impact factor: 4.634

2.  Retention of Patients With Multiple Vulnerabilities in a Federally Qualified Health Center Buprenorphine Program: Pennsylvania, 2017-2018.

Authors:  Lara Carson Weinstein; Qais Iqbal; Amy Cunningham; Robin Debates; Greg Landistratis; Patrick Doggett; Alexis Silverio
Journal:  Am J Public Health       Date:  2020-02-20       Impact factor: 9.308

3.  Disparities in Access to Medications for Opioid Use Disorder in the Veterans Health Administration.

Authors:  Andrea K Finlay; Alex H S Harris; Christine Timko; Mengfei Yu; David Smelson; Matthew Stimmel; Ingrid A Binswanger
Journal:  J Addict Med       Date:  2021-04-01       Impact factor: 4.647

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.